Calcium acetate or calcium carbonate for hyperphosphatemia of hemodialysis patients: a meta-analysis. - Wikidata - wikimedia - TriplyDB

Calcium acetate or calcium carbonate for hyperphosphatemia of hemodialysis patients: a meta-analysis.

Calcium acetate or calcium carbonate for hyperphosphatemia of hemodialysis patients: a meta-analysis.

http://www.wikidata.org/entity/Q35209016

about

Cost Effectiveness of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in the Treatment of Hyperphosphataemia in Patients Receiving Dialysis, from the Perspective of the National Health Service in Scotland.

P2860

Q36322947-1C40B82E-6523-406B-A58C-88B9080F1EA6

P2860

Calcium acetate or calcium carbonate for hyperphosphatemia of hemodialysis patients: a meta-analysis.

http://www.wikidata.org/entity/Q35209016

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Calcium acetate or calcium car ...... sis patients: a meta-analysis.

@ast

Calcium acetate or calcium car ...... sis patients: a meta-analysis.

@en

type

label

Calcium acetate or calcium car ...... sis patients: a meta-analysis.

@ast

Calcium acetate or calcium car ...... sis patients: a meta-analysis.

@en

prefLabel

Calcium acetate or calcium car ...... sis patients: a meta-analysis.

@ast

Calcium acetate or calcium car ...... sis patients: a meta-analysis.

@en

P1433

Q35209016-17B6D14F-7921-4D9F-A5DF-8476B4315BF6

P1476

Q35209016-FA19E014-6023-4158-9064-9D9DE1C099FD

P2093

Q35209016-182639C7-6BC3-4ADE-8CD3-1805BB82C0CF

Q35209016-2B6C8DCF-4B60-4B60-8550-299C67A7966D

Q35209016-4E12B74B-7E72-42F8-8C3F-D65B92876AA8

Q35209016-5F5D18A6-A56C-4224-BFEE-DAD21301D734

Q35209016-AE18875C-F886-40E6-9818-3E5F704D09C9

Q35209016-C96857A4-4D93-4040-A8D4-A3CB22033F25

P2860

Q35209016-25566991-4E38-4EC3-87A9-DFBB9CB435E3

Q35209016-38AF0E37-9E05-41EF-BD00-248F75B28AA7

Q35209016-4566753C-8D01-434A-A953-0BC53483D9F2

Q35209016-5060F541-70B5-45A8-87BC-979F1D66DFDF

Q35209016-584391F3-AB21-41E8-84F8-372D53D12C7B

Q35209016-62974031-AE66-4E24-ABCC-F4E06F8C45B4

Q35209016-64ED0AEA-5555-4A03-ABD6-5F17F6E69E61

Q35209016-6A48FE4E-3206-4EF3-BDB1-A519544C563A

Q35209016-6EAF7C2F-75CA-4F8E-BB71-EF49AF541D52

Q35209016-8E520DCF-7A6E-406A-95DA-F8B990946483

P304

Q35209016-E522CA72-2B57-4ABE-8AFD-B0B26C0961C8

P31

Q35209016-A8FED8B4-2655-4B2B-9CB8-734D9A079089

Q35209016-d6de2ba1-5502-4c52-968b-fdd4d71ae2a7

P356

Q35209016-0FA9C7D0-3245-4B21-9804-CC1221C152A0

P407

Q35209016-C9190597-AB24-4D51-BA93-53DBF68B509B

P433

Q35209016-35530E4C-ED1C-4242-94ED-8DFF613509BA

P478

Q35209016-048464C8-191D-4E6D-8FFC-0E9B1966E555

P577

Q35209016-55EA7B55-579B-41B0-BCD9-C983939D5B95

P5875

Q35209016-D053FFB7-F644-4155-B4CE-9144ABB9F854

P698

Q35209016-16D40A2E-56C4-4153-A899-93FF40795066

P932

Q35209016-866C05C9-71F6-4D39-9DB0-67C4B6E76223

P356

JOURNAL.PONE.0121376

P1433

P1476

Calcium acetate or calcium car ...... sis patients: a meta-analysis.

@en

P2093

Bo Yang

http://www.w3.org/2001/XMLSchema#string

Guoqiang Xie

http://www.w3.org/2001/XMLSchema#string

Han Zhang

http://www.w3.org/2001/XMLSchema#string

Yong Wang

http://www.w3.org/2001/XMLSchema#string

Yuanhang Huang

http://www.w3.org/2001/XMLSchema#string

Zhiguo Mao

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphate binders for preventing and treating bone disease in chronic kidney disease patients

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Oral phosphate binders in patients with kidney failure

Comparative effectiveness of calcium acetate and sevelamer on clinical outcomes in elderly hemodialysis patients enrolled in Medicare part D

Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study.

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.

Phosphorus binders and survival on hemodialysis.

Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis.

Hyperphosphatemia among end-stage renal disease patients in developing countries: a forgotten issue?

Comparison of calcium acetate with calcium carbonate as phosphate binder in patients on maintenance haemodialysis.

P304

e0121376

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0121376

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277582374

http://www.w3.org/2001/XMLSchema#string

P698

25799184

http://www.w3.org/2001/XMLSchema#string

P932

4370772

http://www.w3.org/2001/XMLSchema#string